NELSON
Nederlands-Leuvens Longkanker ScreeningsONderzoek / The Dutch-Belgian Randomized Lung Cancer Screening Trial...
Description
The Dutch-Belgian Randomized Lung Cancer Screening Trial (NELSON study) was designed to investigate whether screening for lung cancer by low-dose multidetector computed tomography (CT) in high-risk subjects and led to a decrease in ten year lung canc...
General Design
- Type
- Clinical trial
- Data collection type
- Prospective
- Design
- Longitudinal
- Design description
- Participants were randomized 1:1 in a screening and control group. Participants who were selected for screening were invited to undergo low-dose CT scanning of the chest at baseline, at 1, 3, and 5.5 years after the baseline.
- Design schematic
- Design schematic
- Start/End data collection
- 2000 until 2015
- Design paper
- Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON)
- PID
- https://doi.org/10.34760/65266b301390b
Population
- Countries
- Netherlands (the)
- Number of participants
- 15792
- Population age groups
- Middle-aged (45-64 years), Aged (65-79 years)
- Other inclusion criteria
- More specifically, the population comprised of people born between 1928 and 1956 originating from the Netherlands and Belgium, who: • Smoked > 15 cigarettes/day during > 25 years, • Or smoked > 10 cigarettes/day during > 30 years, • and were current smokers or former smokers who quit smoking ≤ 10 years ago. Excluded were those with a moderate or bad self-reported health who were unable to climb two flights of stairs, those with a body weight ≥ 140 kg, with current or past renal cancer, melanoma or breast cancer, or with lung cancer diagnosed less than 5 years ago, or 5 years or more ago but still under treatment. Also those who had a chest CT examination less than one year before they filled in the first NELSON questionnaire were excluded.
Organisations
Lead organisations
- University Medical Centre Groningen (UMCG)Netherlands (the)https://www.umcg.nl/
Additional organisations
- Erasmus MC (EMC)Netherlands (the)https://www.erasmusmc.nl/
- Kennemer Gasthuis Haarlem (KGH)
- University Hospital Leuven (UHL)
- University Medical Centre Utrecht (UMCU)Netherlands (the)https://www.umcutrecht.nl/
Contributors
- prof. dr. H.J.M. (Harry) GroenUniversity Medical Centre Groningenh.j.m.groen@umcg.nl
Principal Investigator
Available Data & Samples
Data categories
- Biological samples
- Survey data
- Imaging data
- Medical records
- National registries
- Omics
- Genomics
Sample categories
- Genetic material
- DNA
- RNA
Areas of information
- Socio-demographic and economic characteristics
- Age/birthdate
- Sex/gender
- Marital/partner status
- Family and household structure
- Education
- Income, possessions, and benefits
- Lifestyle and behaviours
- Tobacco
- Alcohol
- Physical activity
- Perception of health, quality of life, development and functional limitations
- Perception of health
- Death
- Vital status
- Cause of death
- Other end of life or death-related information
- Physical measures and assessments
- Anthropometry
- Other physical measures and assessments
- Laboratory measures
- Genomics
- Physical environment
- Workplace characteristics
- Administrative information
- Questionnaire and interview-related information
Subpopulations
List of subpopulations for this resource...
Name | Description | Number of participants |
---|
Collection events
List of collection events defined for this resource...
Name | Description | Participants | Start end year |
---|
Publications
Access conditions
The University Medical Centre Groningen maintains individual data, which the NELSON steering committee can make available upon request....
- Data access conditions
- health or medical or biomedical research
- disease specific research
- Data use conditions
- research specific restrictions
- Data access fee
- true
- Release type
- Closed dataset
Funding & Acknowledgements
- Funding
- Supported by the Netherlands Organization of Health Research and Development, the Dutch Cancer Society (KWF Kankerbestrijding), the Health Insurance Innovation Foundation (Innovatiefonds Zorgverzekeraars), G.Ph. Verhagen Stichting, the Rotterdam Oncologic Thoracic Study Group, the Erasmus Trust Fund, Stichting tegen Kanker, Vlaamse Liga tegen Kanker, and Lokaal Gezondheids Overleg (LOGO) Leuven. Siemens Germany provided four workstations and software for volume measurements.